Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial

BACKGROUND: Trigeminal neuralgia is characterized by paroxysmal facial pain attacks. Adequate prophylactic drug therapy is often limited by the lack of efficacy and intolerance due to central nervous system side effects. Subcutaneous injections of botulinum toxin type A are a promising treatment opt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Burmeister, Jan, Holle, Dagny, Bock, Eva, Ose, Claudia, Diener, Hans-Christoph, Obermann, Mark
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669653/
https://ncbi.nlm.nih.gov/pubmed/26634453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-1052-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky